Pharmacotherapy for Non-alcoholic Fatty Liver Disease Associated with Diabetes Mellitus Type 2

Non-alcoholic fatty liver disease (NAFLD) and diabetes mellitus type 2 commonly coexist as a manifestation of metabolic syndrome. The presence of diabetes promotes the progression of simple fatty liver to non-alcoholic steatohepatitis (NASH) and cirrhosis, and the presence of NAFLD increases the ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Koullias, Emmanouil S., Koskinas, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547270/
https://www.ncbi.nlm.nih.gov/pubmed/36304499
http://dx.doi.org/10.14218/JCTH.2021.00564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547270/
https://www.ncbi.nlm.nih.gov/pubmed/36304499
http://dx.doi.org/10.14218/JCTH.2021.00564

Ejemplares similares